ENCYCLE
DEAD

Serial Number

86952001

Owner

Encycle Therapeutics Inc.

Attorney

David J. Byer

Filing Date

Mar 24, 2016

Add to watchlist:

No watchlists yet
View on USPTO

ENCYCLE Trademark

Serial Number: 86952001 • Registration: 5830828

ENCYCLE is a trademark filed by Encycle Therapeutics Inc. on March 24, 2016. The trademark is classified under Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). The application is currently no longer active.

Owner Contact Info

Encycle Therapeutics Inc.

101 College Street, Suite 332
Toronto, Ontario M5G1L7 , CA

Entity Type: 03

Trademark Details

Filing Date

March 24, 2016

Registration Date

August 13, 2019

Published for Opposition

February 13, 2018

Cancellation Date

February 27, 2026

Goods & Services

Pharmaceutical drug development services, namely, the synthesis of macrocycles using amphoteric reagents for drug discovery and discovery of new therapeutic uses for existing pharmaceutical preparations; Research in the field for chemistry for the discovery and production of therapeutic pharmaceutical preparations; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical research services; Scientific research and analysis in the field of drug discovery and pharmaceutical drug development; Drug discovery services; Pharmaceutical research services; Pharmaceutical research and development; Clinical research in the field of gastroenterological science and medicine; Development of pharmaceutical preparations and medicines; Pharmaceutical evaluation services; Conducting early evaluations in the field of new pharmaceuticals; Providing scientific information to scientists, physicians and health care providers; Scientific research, pharmaceutical research, medical research, technical consultation and product development for others in the field of development of pharmaceuticals

Licensing of patent and intellectual property rights arising from medical and pharmaceutical research and development activities; Licensing of proprietary intellectual property

Brokerage services, namely, acquisition and divestiture of patent and intellectual property rights arising from medical and pharmaceutical research and development activities; Brokerage services to commercialize research and development outcomes in the field of medicine, pharmacy, biology, chemistry and medicine-technology; Brokerage services to commercialize research and development projects in the field of medicine, pharmacy, biology, chemistry and medicine-technology

Filing History

CANCELLED SEC. 8 (6-YR)
Feb 27, 2026 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 13, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Aug 13, 2019 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Jul 8, 2019 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 8, 2019 AITU
NOTICE OF ALLOWANCE CANCELLED
Jun 24, 2019 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Jun 24, 2019 D1BR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 11, 2019 EXRA
SOU EXTENSION 2 GRANTED
Apr 9, 2019 EX2G
SOU EXTENSION 2 FILED
Apr 9, 2019 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 9, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 10, 2018 EXRA
SOU EXTENSION 1 GRANTED
Oct 8, 2018 EX1G
SOU EXTENSION 1 FILED
Oct 8, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 8, 2018 EEXT
ASSIGNED TO EXAMINER
May 16, 2018 DOCK
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 10, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 13, 2018 NPUB
PUBLISHED FOR OPPOSITION
Feb 13, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 24, 2018 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Jan 8, 2018 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Dec 29, 2017 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 21, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 21, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 21, 2017 CRFA
ASSIGNED TO LIE
Dec 20, 2017 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 13, 2017 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jul 12, 2017 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jul 12, 2017 GNSI
SUSPENSION INQUIRY WRITTEN
Jul 12, 2017 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 11, 2017 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 11, 2017 GNSL
SUSPENSION LETTER WRITTEN
Jan 11, 2017 CNSL
EXAMINER'S AMENDMENT ENTERED
Dec 20, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 20, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 20, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 20, 2016 CNEA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 12, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 12, 2016 GNRN
NON-FINAL ACTION E-MAILED
Jul 12, 2016 GNRT
NON-FINAL ACTION WRITTEN
Jul 12, 2016 CNRT
ASSIGNED TO EXAMINER
Jul 6, 2016 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Mar 30, 2016 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 29, 2016 NWOS
NEW APPLICATION ENTERED
Mar 28, 2016 NWAP